{"date":"2025-04-24","count":18,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6929-2025-04-24-1956-xp57kx","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"19:56:07","subject":"公告本公司114年第一季個別財務報告預計提報董事會日期","clause":"第31款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-04-24 19:56，「公告本公司114年第一季個別財務報告預計提報董事會日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2025-04-24-1936-1orm707","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-04-24","time":"19:36:29","subject":"公告本公司董事會決議盈餘暨資本公積轉增資發行新股案","clause":"第9款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2025-04-24 19:36，「公告本公司董事會決議盈餘暨資本公積轉增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2025-04-24-1926-11wjw0o","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-04-24","time":"19:26:26","subject":"公告本公司董事會決議股利分派","clause":"第31款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2025-04-24 19:26，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-04-24-1854-12cdid5","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"18:54:31","subject":"本公司異體間質幹細胞治療新藥HeXell-2020獲美國食品藥物管理局(FDA)准予治療冠狀動脈心臟病Coronary Artery Disease(CAD)Phase I/IIa人體臨床試驗之執行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-04-24 18:54，「本公司異體間質幹細胞治療新藥HeXell-2020獲美國食品藥物管理局(FDA)准予治療冠狀動脈心臟病Coronary 」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-04-24-1746-1ywm393","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"17:46:49","subject":"本公司「EFAI CHESTSUITE XR MALPOSITIONED ETTASSESSMENT SYSTEM」獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-04-24 17:46，「本公司「EFAI CHESTSUITE XR MALPOSITIONED ETTASSESSMENT SYSTEM」獲得」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2025-04-24-1721-1hku5w3","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-04-24","time":"17:21:57","subject":"公告本公司董事會通過113年度合併財務報告","clause":"第43款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2025-04-24 17:21，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2025-04-24-1720-18h7z3n","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-04-24","time":"17:20:27","subject":"公告本公司董事會決議113年度員工及董事酬勞分派案","clause":"第44款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2025-04-24 17:20，「公告本公司董事會決議113年度員工及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-04-24-1650-1g447jl","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"16:50:41","subject":"公告本公司有關人員涉嫌違反證券交易法乙案，經臺灣新北地方法院刑事判決結果說明","clause":"第2款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-04-24 16:50，「公告本公司有關人員涉嫌違反證券交易法乙案，經臺灣新北地方法院刑事判決結果說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2025-04-24-1609-1ydt6ng","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"16:09:41","subject":"公告114年第1季財務報告董事會預計召開日期為114年5月2日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2025-04-24 16:09，「公告114年第1季財務報告董事會預計召開日期為114年5月2日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-04-24-1529-11slo5o","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-04-24","time":"15:29:44","subject":"本公司董事會決議擬與Avenue Therapeutics, Inc.簽署「授權終止與計畫轉移協議」，重新主導AJ201後續之臨床開發與全球授權。","clause":"第8款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-04-24 15:29，「本公司董事會決議擬與Avenue Therapeutics, Inc.簽署「授權終止與計畫轉移協議」，重新主導AJ201」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-04-24-1515-1jia6er","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-04-24","time":"15:15:19","subject":"公告本公司股票即將終止興櫃交易並轉至臺灣證券交易所上巿交易","clause":"第28款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-04-24 15:15，「公告本公司股票即將終止興櫃交易並轉至臺灣證券交易所上巿交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-04-24-1514-icvqfo","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-04-24","time":"15:14:47","subject":"公告本公司辦理股票初次上市過額配售內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-04-24 15:14，「公告本公司辦理股票初次上市過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-04-24-1514-orh8r2","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-04-24","time":"15:14:22","subject":"公告本公司辦理股票初次上市前現金增資收足股款暨現金增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-04-24 15:14，「公告本公司辦理股票初次上市前現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2025-04-24-1502-vblh8z","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2025-04-24","time":"15:02:18","subject":"公告本公司114年第一季財務報告董事會預計召開日期為114年5月2日","clause":"第31款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2025-04-24 15:02，「公告本公司114年第一季財務報告董事會預計召開日期為114年5月2日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-04-24-1444-1s04pqb","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"14:44:54","subject":"公告本公司董事會決議召開114年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-04-24 14:44，「公告本公司董事會決議召開114年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-04-24-1429-ywsbec","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"14:29:17","subject":"本公司董事會決議限制員工權利新股增資基準日案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-04-24 14:29，「本公司董事會決議限制員工權利新股增資基準日案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-04-24-1428-uuutvt","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-04-24","time":"14:28:02","subject":"公告本公司民國114年第一季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-04-24 14:28，「公告本公司民國114年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-04-24-1422-qkw3o","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-04-24","time":"14:22:11","subject":"公告本公司114年第一季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-04-24 14:22，「公告本公司114年第一季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}